½ÃÀ庸°í¼­
»óǰÄÚµå
1602406

¼¼°èÀÇ À¯Âø ¹æÁöÁ¦ ½ÃÀå : Á¦Ç°º°, Á¦Á¦º°, ¿ëµµº° - ¿¹Ãø(2025-2030³â)

Adhesion Barrier Market by Product (Natural Adhesion Barriers, Synthetic Adhesion Barriers), Formulation (Film/Mesh, Gel, Liquid), Application - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 193 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

À¯Âø ¹æÁöÁ¦ ½ÃÀåÀº 2023³â¿¡ 8¾ï 1,037¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 8¾ï 6,669¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, CAGR 7.29%·Î ¼ºÀåÇÒ Àü¸ÁÀ̰í, 2030³â¿¡´Â 13¾ï 2,676¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

À¯Âø ¹æÁöÁ¦´Â ¼ö¼ú ÈÄ À¯ÂøÀ» ¹æÁöÇÏ´Â µ¥ »ç¿ëµÇ´Â ÀÇ·á±â±âÀÔ´Ï´Ù. À¯ÂøÀ̶õ ¼ö¼ú ÈÄ Á¶Á÷À̳ª Àå±â »çÀÌ¿¡ Çü¼ºµÇ´Â ¼¶À¯ ¸ð¾çÀÇ ¶ì¸¦ ¸»Çϸç, ÇÕº´ÁõÀ» ÀÏÀ¸Å³ ¼ö ÀÖ½À´Ï´Ù. À¯Âø ¹æÁöÁ¦ÀÇ Çʿ伺Àº À¯ÂøÀÌ ÀåÆó»ö, ºÒÀÓ, ¸¸¼º ÅëÁõ µîÀÇ ½É°¢ÇÑ ¹®Á¦¸¦ ÀÏÀ¸Å³ ¼ö ÀÖ´Â ºÎÀΰú, º¹ºÎ, Á¤Çü¿Ü°ú µîÀÇ ¿Ü°ú ¼ö¼ú¿¡¼­ »ý±ä´Ù. ÀÌ·¯ÇÑ ¹æÁöÁ¦´Â ÀϹÝÀûÀ¸·Î Çʸ§, Á© ¶Ç´Â ¾×ü·Î ÀÔ¼ö °¡´ÉÇÏ¸ç º´¿ø, Áø·á ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)¿¡ °ÉÄ£ ¿ëµµ·Î »ç¿ëµÇ°í ¼ö¼ú °á°ú¿Í ȸº¹ °æÇè¿¡ Å« ¿µÇâÀ» ¹ÌĨ´Ï´Ù. À¯Âø ¹æÁöÁ¦¿¡ ´ëÇÑ ¼¼°èÀÇ ¼ö¿ä´Â ¼ö¼ú °Ç¼öÀÇ Áõ°¡, ³ëÀÎ Àα¸ÀÇ Áõ°¡, ¸é¹ÐÇÑ Á¤È®µµ¿Í ¹è·Á¸¦ ÇÊ¿ä·Î ÇÏ´Â ¿Ü°ú ¼ö¼úÀÇ Áøº¸¿¡ µû¶ó¼­ ÃßÁøµÇ°í ÀÖ½À´Ï´Ù. ÃÖ±Ù ½ÃÀå ¼ºÀåÀº Çõ½ÅÀûÀÎ Á¦Ç° µ¿Çâ°ú ¼ö¼ú ÈÄ À¯Âø ÇÕº´Áõ¿¡ ´ëÇÑ ÀÇ½Ä Áõ°¡¿¡µµ ¿µÇâÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ½ÅÈï±¹ ½ÃÀåÀ» Ÿ±êÀ¸·Î ºÎÀÛ¿ë ¾øÀÌ Ã¼³»¿¡¼­ È¿À²ÀûÀ¸·Î ºÐÇØµÇ´Â »ýºÐÇØ¼ºÀ¸·Î º¸´Ù È¿°úÀûÀÎ Á¦Ç°À» °³¹ßÇÒ ¼ö ÀÖ´Â ±âȸ°¡ ÀÖ½À´Ï´Ù. ±×·¯³ª ½ÃÀå ¼ºÀåÀº ³ôÀº Á¦Ç° ºñ¿ë, ³ª¶ó¸¶´Ù ´Ù¸¥ ±ÔÁ¦ ¿ä°Ç, Àú¼Òµæ Áö¿ª¿¡¼­ ³·Àº Á¦Ç° ÀÎÁöµµ¶ó°í ÇÏ´Â ÇѰ迡 Á÷¸éÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ °úÁ¦¸¦ ±Øº¹Çϱâ À§Çؼ­, ±â¾÷Àº Çõ½ÅÀûÀÎ Á¦Á¦ÀÇ ¿¬±¸ °³¹ß¿¡ ÅõÀÚÇϰí, Àü·«Àû ÆÄÆ®³Ê½ÊÀ» Ȱ¿ëÇØ ½ÃÀåÀ» È®´ëÇÏ´Â µ¥ ÁÖ·ÂÇØ¾ß ÇÕ´Ï´Ù. »ýü Èí¼ö¼º Á¦Á¦³ª µå·¡±× µô¸®¹ö¸® ±â´ÉÀ» ÅëÇÕÇÑ °Í°ú °°Àº È¿À²¼ºÀ» Çâ»ó½ÃŰ´Â Á¶ÇÕÇü À̳뺣ÀÌ¼Ç µîÀÇ ±æÀ» ã´Â´Ù¸é Á¦Ç°ÀÇ °¡Ä¡¿Í ¼ö¿ë¼ºÀ» Å©°Ô ³ôÀÏ ¼ö ÀÖÀ» °ÍÀ¸·Î »ý°¢µË´Ï´Ù. ³ª¾Æ°¡ ÇöÁö »ý»ê°ú Æ÷°ýÀûÀÎ ¸¶ÄÉÆÃ Àü·«À» ÅëÇØ Áö¸® ¹× ±ÔÁ¦Àû À庮¿¡ ´ëóÇÔÀ¸·Î½á ½ÃÀå¿¡¼­ÀÇ ÁöÀ§¸¦ ´õ¿í °ø°íÈ÷ ÇÒ ¼ö ÀÖ½À´Ï´Ù. ½ÃÀåÁ¤¼¼´Â ¼¼ºÐÈ­µÇ°í °æÇÕÀÌ ²÷ÀÌÁö ¾ÊÀ¸¹Ç·Î ¾÷°èÀÇ ¼ºÀåÀ» À¯Áö ¹× °­È­Çϱâ À§Çؼ­´Â Áö¼ÓÀûÀÎ °³¼±°ú Áö¿ªÀÇ ¿ä±¸¿¡ ´ëÇÑ ÀûÀÀÀÌ ÇÊ¿äÇÕ´Ï´Ù

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023³â) 8¾ï 1,037¸¸ ´Þ·¯
¿¹Ãø³â(2024³â) 8¾ï 6,669¸¸ ´Þ·¯
¿¹Ãø³â(2030³â) 13¾ï 2,676¸¸ ´Þ·¯
CAGR(%) 7.29%

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â À¯Âø ¹æÁöÁ¦ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

À¯Âø ¹æÁöÁ¦ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ð¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÅõÀÚ°áÁ¤, Àü·«Àû °áÁ¤ Á¤¹ÐÈ­, »õ·Î¿î ºñÁî´Ï½º ±âȸ ȹµæ¿¡ ´ëºñÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦ÀûÀÎ ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ½°ú µ¿½Ã¿¡, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ëÀ̳ª ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¼¼°èÀÇ ³ëÀÎ Àα¸ Áõ°¡¿Í ÀÇ·á ¼ö¼ú °Ç¼ö Áõ°¡
    • Àç°Ç ¼ö¼úÀÇ Çʿ伺 Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • À¯Âø ¹æÁöÁ¦°ú °ü·ÃµÈ ¼ö¼ú ÈÄ ÇÕº´Áõ
  • ½ÃÀå ±âȸ
    • »õ·Î¿î À¯Âø ¹æÁöÁ¦¸¦ µµÀÔÇϱâ À§ÇÑ Áö¼ÓÀûÀÎ ¿¬±¸ °³¹ß
    • ½ÅÈï °æÁ¦ ±¹°¡¿¡¼­ÀÇ Çö´ëÀû °Ç°­ °ü¸® ÀÎÇÁ¶óÀÇ ¹ßÀü
  • ½ÃÀåÀÇ °úÁ¦
    • ¾ö°ÝÈ÷ ½Ã°£ÀÌ °É¸®´Â ±ÔÁ¦ ÇÁ·Î¼¼½º

Porter's Five Forces : À¯Âø ¹æÁöÁ¦ ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲÀÇ °æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ޱ¸ÇÏ´Â ¸íÈ®ÇÑ ±â¼úÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®¸¦ ÅëÇØ ±â¾÷Àº ÀÚ»çÀÇ °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ °úÁ¦¸¦ ÇÇÇÒ ¼ö ÀÖÀ¸¸ç, º¸´Ù °­ÀÎÇÑ ½ÃÀå¿¡¼­ÀÇ Æ÷Áö¼Å´×À» º¸ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : À¯Âø ¹æÁöÁ¦ ½ÃÀå¿¡¼­ ¿ÜºÎ·ÎºÎÅÍÀÇ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº À¯Âø ¹æÁöÁ¦ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¾ÕÀ¸·Î ¿¹»óµÇ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : À¯Âø ¹æÁöÁ¦ ½ÃÀå¿¡¼­ °æÀï ±¸µµ ÆÄ¾Ç

À¯Âø ¹æÁöÁ¦ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü µî ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀï Æ÷Áö¼Å´×À» ¹àÈú ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀå ÁýÁß, ´ÜÆíÈ­, ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í º¥´õµéÀº °æÀïÀÌ Ä¡¿­ÇØÁö´Â °¡¿îµ¥ ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : À¯Âø ¹æÁöÁ¦ ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â À¯Âø ¹æÁöÁ¦ ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÞÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °ø±Þ¾÷üÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±âÁØÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ¸Â´Â ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ °ø±Þ¾÷ü¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ºÎ¹®È­Çϰí Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ : À¯Âø ¹æÁöÁ¦ ½ÃÀå¿¡¼­ ¼º°ø¿¡ ´ëÇÑ °æ·Î¸¦ ±×¸³´Ï´Ù.

À¯Âø ¹æÁöÁ¦ ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠°­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÎ ¿ä¼ÒÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ´É·Â ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í °³¼±À» À§ÇØ ³ë·ÂÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·ÂÀ» Æò°¡ÇÕ´Ï´Ù.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, ¿¬±¸°³¹ß Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð ¹× ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ ¹× ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À² ¹× °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ¼¼°è¿¡¼­ ³ëÀÎ Àα¸ Áõ°¡ ¹× ÀÇ·á ¼ö¼ú ¼ö Áõ°¡
      • Àç°Ç ¼ö¼úÀÇ Çʿ伺 Áõ°¡
    • ¾ïÁ¦¿äÀÎ
      • À¯Âø ¹æÁöÁ¦°ú °ü·ÃµÈ ¼ö¼ú ÈÄ ÇÕº´Áõ
    • ±âȸ
      • »õ·Î¿î À¯Âø ¹æÁöÁ¦ µµÀÔÀ» À§ÇÑ Áö¼ÓÀûÀÎ ¿¬±¸ °³¹ß
      • °æÁ¦ Àüü¿¡ °ÉÄ£ Çö´ëÀûÀÎ ÇコÄɾî ÀÎÇÁ¶ó °³¹ß
    • °úÁ¦
      • ¾ö°ÝÇÏ°í ½Ã°£ÀÌ °É¸®´Â ±ÔÁ¦ ÇÁ·Î¼¼½º
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå À¯Âø ¹æÁöÁ¦ ½ÃÀå : Á¦Ç°º°

  • õ¿¬ À¯Âø ¹æÁöÁ¦
    • Äݶó°Õ°ú ´Ü¹éÁú
    • ÇǺ기
  • ÇÕ¼º À¯Âø ¹æÁöÀç
    • È÷¾Ë·ç·Ð»ê
    • Æú¸®¿¡Æ¿·»±Û¸®ÄÝ
    • Àç»ý ¼¿·ê·Î¿À½º

Á¦7Àå À¯Âø ¹æÁöÁ¦ ½ÃÀå : ó¹æº°

  • Çʸ§ ¹× ¸Þ½¬
  • °Ö
  • ¾×ü

Á¦8Àå À¯Âø ¹æÁöÁ¦ ½ÃÀå : ¿ëµµº°

  • ½ÉÀåÇ÷°ü ¼ö¼ú
  • ÀÏ¹Ý ¼ö¼ú ¹× º¹ºÎ ¼ö¼ú
  • ºÎÀΰú ¼ö¼ú
  • ½Å°æ¿Ü°ú
  • Á¤Çü¿Ü°ú ¼ö¼ú
  • Àç°Ç ¼ö¼ú
  • ºñ´¢±â°ú ¼ö¼ú

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ À¯Âø ¹æÁöÁ¦ ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ À¯Âø ¹æÁöÁ¦ ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ À¯Âø ¹æÁöÁ¦ ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º(2023³â)
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼® ¹× Á¦¾È

±â¾÷ ¸ñ·Ï

  • AlloSource
  • Anika Therapeutics, Inc.
  • Baxter International, Inc.
  • Becton Dickinson and Company
  • Betatech Medical
  • Bioscompass, Inc.
  • CG Bio Inc.
  • CorMatrix Cardiovascular, Inc.
  • Endotherapeutics Pty. Ltd.
  • FzioMed, Inc.
  • Getinge AB
  • Gunze Limited
  • Hangzhou Singclean Medical Products Co.,Ltd
  • Innocoll Holdings Public Limited Company
  • Integra LifeSciences Corporation
  • Johnson & Johnson Services, Inc.
  • Koninklijke DSM NV
  • Leader Biomedical
  • Luna Innovations Incorporated
  • MAST Biosurgery AG
  • Omnia Health by Informa PLC
  • SEMICAL
  • Smith & Nephew PLC
  • Stryker Corporation
  • WL Gore & Associates, Inc.
  • Womed SAS
  • Terumo Corporation
AJY 24.12.10

The Adhesion Barrier Market was valued at USD 810.37 million in 2023, expected to reach USD 866.69 million in 2024, and is projected to grow at a CAGR of 7.29%, to USD 1,326.76 million by 2030.

Adhesion barriers are medical devices used to prevent post-operative adhesions, which are fibrous bands that form between tissues and organs following surgery and can lead to complications. The necessity of adhesion barriers arises in surgical procedures such as gynecological, abdominal, and orthopedic operations, where adhesions can cause serious issues like bowel obstruction, infertility, or chronic pain. These barriers are typically available as films, gels, or liquids and serve applications spanning hospitals, clinics, and ambulatory surgical centers, influencing the surgical outcomes and recovery experience significantly. The global demand for adhesion barriers is being propelled by the increasing volume of surgeries, a growing elderly population, and advancements in surgical procedures that require meticulous precision and care. Recent market growth is further influenced by innovative product developments and an expanding awareness of post-surgical adhesion complications. Opportunities lie in targeting emerging markets and developing biodegradable and more effective products that can efficiently degrade in the body without triggering side effects. However, market growth faces limitations such as high product costs, diverse regulatory requirements across different countries, and limited product awareness in low-income regions. To overcome these challenges, companies should focus on investing in R&D for innovative formulations and harnessing strategic partnerships to expand market reach. Exploring avenues like bioresorbable products and combinational innovations that improve efficiency, such as those integrating drug-delivery capabilities, could significantly enhance product value and acceptance. In addition, addressing geographical and regulatory barriers through localized production and comprehensive marketing strategies can further consolidate market positions. The market nature remains competitive with a fragmented landscape, necessitating continuous improvement and adaptation to regional needs to sustain and bolster growth in the adhesion barrier industry.

KEY MARKET STATISTICS
Base Year [2023] USD 810.37 million
Estimated Year [2024] USD 866.69 million
Forecast Year [2030] USD 1,326.76 million
CAGR (%) 7.29%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Adhesion Barrier Market

The Adhesion Barrier Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising geriatric population worldwide coupled with increasing number of medical surgeries
    • Growing need for reconstructive surgeries
  • Market Restraints
    • Post-surgical complication associated with adhesion barriers
  • Market Opportunities
    • Ongoing research and development to introduce new adhesion barriers
    • Development of modern healthcare infrastructure across economies
  • Market Challenges
    • Stringent and time consuming regulatory processes

Porter's Five Forces: A Strategic Tool for Navigating the Adhesion Barrier Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Adhesion Barrier Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Adhesion Barrier Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Adhesion Barrier Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Adhesion Barrier Market

A detailed market share analysis in the Adhesion Barrier Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Adhesion Barrier Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Adhesion Barrier Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Adhesion Barrier Market

A strategic analysis of the Adhesion Barrier Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Adhesion Barrier Market, highlighting leading vendors and their innovative profiles. These include AlloSource, Anika Therapeutics, Inc., Baxter International, Inc., Becton Dickinson and Company, Betatech Medical, Bioscompass, Inc., CG Bio Inc., CorMatrix Cardiovascular, Inc., Endotherapeutics Pty. Ltd., FzioMed, Inc., Getinge AB, Gunze Limited, Hangzhou Singclean Medical Products Co.,Ltd, Innocoll Holdings Public Limited Company, Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., Koninklijke DSM N.V., Leader Biomedical, Luna Innovations Incorporated, MAST Biosurgery AG, Omnia Health by Informa PLC, SEMICAL, Smith & Nephew PLC, Stryker Corporation, W. L. Gore & Associates, Inc., Womed SAS, and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Adhesion Barrier Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Natural Adhesion Barriers and Synthetic Adhesion Barriers. The Natural Adhesion Barriers is further studied across Collagen & Protein and Fibrin. The Synthetic Adhesion Barriers is further studied across Hyaluronic Acid, Polyethylene Glycol, and Regenerated Cellulose.
  • Based on Formulation, market is studied across Film/Mesh, Gel, and Liquid.
  • Based on Application, market is studied across Cardiovascular Surgeries, General/Abdominal Surgeries, Gynecological Surgeries, Neurological Surgeries, Orthopedic Surgeries, Reconstructive Surgeries, and Urological Surgeries.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising geriatric population worldwide coupled with increasing number of medical surgeries
      • 5.1.1.2. Growing need for reconstructive surgeries
    • 5.1.2. Restraints
      • 5.1.2.1. Post-surgical complication associated with adhesion barriers
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing research and development to introduce new adhesion barriers
      • 5.1.3.2. Development of modern healthcare infrastructure across economies
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent and time consuming regulatory processes
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Adhesion Barrier Market, by Product

  • 6.1. Introduction
  • 6.2. Natural Adhesion Barriers
    • 6.2.1. Collagen & Protein
    • 6.2.2. Fibrin
  • 6.3. Synthetic Adhesion Barriers
    • 6.3.1. Hyaluronic Acid
    • 6.3.2. Polyethylene Glycol
    • 6.3.3. Regenerated Cellulose

7. Adhesion Barrier Market, by Formulation

  • 7.1. Introduction
  • 7.2. Film/Mesh
  • 7.3. Gel
  • 7.4. Liquid

8. Adhesion Barrier Market, by Application

  • 8.1. Introduction
  • 8.2. Cardiovascular Surgeries
  • 8.3. General/Abdominal Surgeries
  • 8.4. Gynecological Surgeries
  • 8.5. Neurological Surgeries
  • 8.6. Orthopedic Surgeries
  • 8.7. Reconstructive Surgeries
  • 8.8. Urological Surgeries

9. Americas Adhesion Barrier Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Adhesion Barrier Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Adhesion Barrier Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AlloSource
  • 2. Anika Therapeutics, Inc.
  • 3. Baxter International, Inc.
  • 4. Becton Dickinson and Company
  • 5. Betatech Medical
  • 6. Bioscompass, Inc.
  • 7. CG Bio Inc.
  • 8. CorMatrix Cardiovascular, Inc.
  • 9. Endotherapeutics Pty. Ltd.
  • 10. FzioMed, Inc.
  • 11. Getinge AB
  • 12. Gunze Limited
  • 13. Hangzhou Singclean Medical Products Co.,Ltd
  • 14. Innocoll Holdings Public Limited Company
  • 15. Integra LifeSciences Corporation
  • 16. Johnson & Johnson Services, Inc.
  • 17. Koninklijke DSM N.V.
  • 18. Leader Biomedical
  • 19. Luna Innovations Incorporated
  • 20. MAST Biosurgery AG
  • 21. Omnia Health by Informa PLC
  • 22. SEMICAL
  • 23. Smith & Nephew PLC
  • 24. Stryker Corporation
  • 25. W. L. Gore & Associates, Inc.
  • 26. Womed SAS
  • 27. Terumo Corporation
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦